Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets
Rusan Pharma expands its global footprint with TGA and ANVISA GMP certifications for its transdermal patch and oral film…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
buprenorphine
Global opioid use disorder market to reach $3.7 bn by 2028: GlobalData
The main driver of growth will be the launch of reformulations of buprenorphine, in particular, extended-release formulations